CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 304 enrolled
Drug / intervention
Calcium sodium phosphosilicate +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02371616
NCT02371616N/ACompleted

A Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity

GlaxoSmithKline·interventional·Posted Feb 25, 2015·Updated Apr 4, 2018

In Brief

A clinical study evaluating Calcium sodium phosphosilicate, Sodium fluoride, and 1 other intervention for Dentine Sensitivity. Completed, enrolled 304 participants across 3 sites.

Detailed Summary

An 8 week clinical study to evaluate the ability of an experimental dentifrice containing calcium sodium phosphosilicate and sodium fluoride to provide relief from dentine hypersensitivity compared to a marketed dentifrice containing calcium sodium phosphosilicate and sodium monofluorophosphate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 25, 2015
Enrollment StartSep 29, 2014
Primary CompletionDec 18, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.4 years ago

Interventions

Calcium sodium phosphosilicatedevice

5% w/w calcium sodium phosphosilicate

Sodium fluorideother

1426 ppm fluoride as sodium fluoride

Sodium monofluorophosphateother

1426 ppm fluoride as sodium monofluorophosphate